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Catheter-Associated Bloodstream Infections in General Medical
Patients Outside the Intensive Care Unit: A Surveillance Study
Jonas Marschall, MD; Carole Leone, RN; Marilyn Jones, RN;
Deborah Nihill, RN; Victoria J. Fraser, MD; David K. Warren, MD, MPH
objective. To determine the incidence of central venous catheter (CVC)–associated bloodstream infection (CA-BSI) among patients
admitted to general medical wards outside the intensive care unit (ICU).
design. Prospective cohort study performed over a 13-month period, from April 1, 2002, through April 30, 2003.
setting. Four selected general medical wards at Barnes-Jewish Hospital, a 1,250-bed teaching hospital in Saint Louis, Missouri.
patients. All patients admitted to 4 general medical wards.
results. A total of 7,337 catheter-days were observed during 33,174 patient-days. The device utilization ratio (defined as the number
of catheter-days divided by the number of patient-days) was 0.22 overall and was similar among the 4 wards (0.21, 0.25, 0.19, and 0.24).
Forty-two episodes of CA-BSI were identified (rate, 5.7 infections per 1,000 catheter-days). Twenty-four (57%) of the 42 cases of CA-BSI
were caused by gram-positive bacteria: 10 isolates (24%) were coagulase-negative staphylococci, 10 (24%) were Enterococcus species, and
3 (7%) were Staphylococcus aureus. Gram-negative bacteria caused 7 infections (17%). Five CA-BSIs (12%) were caused by Candida albicans,
and 5 infections (12%) had a polymicrobial etiology. Thirty-five patients (83%) with CA-BSI had nontunneled CVCs in place.
conclusions. Non-ICU medical wards in the study hospital had device utilization rates that were considerably lower than those of
medical ICUs, but CA-BSI rates were similar to CA-BSI rates in medical ICUs in the United States. Studies of catheter utilization and on
CVC insertion and care should be performed on medical wards. CA-BSI prevention strategies that have been used in ICUs should be
studied on medical wards.
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Nosocomial infections are a major cause of morbidity and
mortality in healthcare systems worldwide and lead to in-
creased healthcare costs. Surveillance for nosocomial infec-
tions is an established method to benchmark hospital infec-
tion rates, compare infection rates over time,1 and serve as
a quality indicator for infection control.2 Accurate and con-
sistent surveillance data are essential to evaluate interventions
to reduce the rate of nosocomial infections. The process of
surveillance in itself, with appropriate feedback, has been
shown to reduce rates of hospital-acquired infections.3
Much of the effort to detect catheter-associated blood-
stream infections (CA-BSIs) has been focused on intensive
care units (ICUs), where the rate of infection tends to be
high because of patients with significant underlying diseases,
long hospitalization durations, and extended periods of cen-
tral venous catheter use. Nontunneled central venous cath-
eters, which are commonly used in the ICU, stand out as a
significant risk factors for CA-BSI, and interventions to pre-
vent CA-BSI have primarily involved these catheters.4-6 How-
ever, the majority of nontunneled central venous catheters in
use in hospitals at any one time are present in non-ICU
patients7 and tend to remain in these patients for longer
durations, without a clear clinical indication for their use.8
Interestingly, the epidemiology of CA-BSI has rarely been
investigated outside the ICU setting. A recent study high-
lighted the influence of central venous catheters and urinary
catheters on infections in non-ICU patients and demon-
strated several differences between non-ICU and ICU pa-
tients.9 These data were collected for non-ICU patients in 42
German hospitals and are derived from the German sur-
veillance system for nosocomial infections, using Centers for
Disease Control and Prevention (CDC) definitions. Although
this study provides the largest source of benchmark data for
CA-BSI in non-ICU patients to date, similar benchmark data
do not exist for US hospitals in non-ICU wards. Key differ-
ences in delivery of care, such as hospital length of stay, exist
between healthcare systems in Europe and other countries
and those in the United States. Therefore, it is unclear whether
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table 1. Central Venous Catheter (CVC) Utilization and Catheter-Associated
Bloodstream Infection (CA-BSI) Rates for 4 General Medicine Wards at a Teach-
ing Hospital in St. Louis, Missouri
Variable Ward A Ward B Ward C Ward D Total
No. of CVC-days 1,704 1,989 1,610 2,034 7,337
No. of patient-days 7,978 8,112 8,618 8,466 33,174
Catheter utilization ratioa 0.21 0.25 0.19 0.24 0.22
CA-BSI rateb 5.3 8.0 4.3 4.9 5.7
a Defined as the number of CVC-days divided by the number of patient-days.
b Defined as the number of CA-BSIs per 1,000 catheter-days.
findings of the study by Vonberg et al.,9 which are from a
European healthcare system, are applicable in the United
States. The purpose of our study was to determine the rate
of catheter-related bloodstream infections in non-ICU med-
ical patients by developing a prospective surveillance program
for non-ICU CA-BSI in a major teaching hospital.
methods
Setting
Barnes-Jewish Hospital, a 1,250-bed teaching hospital, is the
largest hospital in Missouri. It employs 7 infection control
specialists and their support staff. Surveillance for catheter-
associated BSI has been performed in the 6 ICUs. In 2002,
interest in CA-BSI on general medical wards increased. It was
hypothesized that patients on non-ICU wards at Barnes-Jew-
ish Hospital might be at substantial risk for CA-BSI at rates
comparable to CA-BSI rates for ICU patients. To determine
whether this was true, 4 general medical wards (A, B, C, and
D) were selected for prospective CA-BSI surveillance. Each
ward has separate nursing staff. A medical director, interns,
residents, and a nurse manager are shared between wards A
and B; a different group of staff is shared by wards C and D.
Three wards are 26-bed units, and one (ward D) is a 27-bed
unit, for a total of 105 patient beds available for study. Each
ward received 5-10 new patient admissions daily at the time
of the study.
Data Collection and Definitions
A single infection control specialist (C.L.) performed pro-
spective active surveillance for CA-BSI on the 4 selected gen-
eral medical wards from April 1, 2002, through April 30, 2003.
The time required was 2-4 hours per week. All blood cultures
with positive results from these units were reviewed after
identification through GermWatcher, a locally developed
computer-based infection control tool.10
Data were gathered on catheter start and stop dates, as well
as the type of catheter in use, from computerized patient
charts. Catheters could be inserted by emergency department
physicians, house officers, anesthesiologists, or interventional
radiologists. The location of catheter insertion was not re-
corded. Information on length of hospital stay was taken from
the hospital’s medical informatics system. Central venous
catheter–days were defined as days with 1 or more central
venous catheters in place and were obtained from an elec-
tronic report based on the nurses’ documentation. The type
of central venous catheter was documented (for CA-BSI cases
only) and classified as tunneled, nontunneled, peripherally
inserted, or implanted, using an established classification
model.11 The device utilization ratio was defined as the total
number of patient-days with a central venous catheter in situ
per total number of patient-days for each unit.
CA-BSIs were defined using CDC criteria.12 The criteria to
determine whether BSIs were catheter associated were de-
veloped by O’Grady et al.13 A CA-BSI was considered to be
related to a specific unit if detected at least 48 hours after
admission to or less than 48 hours after discharge from the
unit.
Interventions During the Study Period
In the first quarter of 2002, the nursing practice committees
of all 4 wards were introduced to the study and the concept
of surveillance. Subsequently, monthly rates of BSI were re-
corded quarterly for each of the 4 wards and discussed during
these meetings. To raise awareness for proper infection con-
trol measures, a mandatory educational module on the pre-
vention and control of CA-BSI for all nurses on wards A and
B was started in December of 2002 (ie, 9 months after sur-
veillance started). This module included an introduction into
the concept of surveillance, the causes of and risk factors for
nosocomial infection in general and CA-BSI in particular, the
epidemiology of CA-BSI, and proper infection control mea-
sures to prevent CA-BSI.
Data Analysis
Microsoft Excel 2003 was used for data entry and for cal-
culation of means, rate ratios, and confidence intervals (CIs).
For the x2 test, the CDC’s Web-based 2005 Epi Info program
was used (available at: http://www.cdc.gov/epiinfo/).
results
Catheter-Days and Device Utilization Rates
A total of 33,174 patient-days and 7,337 central venous cath-
eter–days were observed during the study period. The
monthly mean number of CVC-days per ward was 141 (range,
77-215 CVC-days). The overall device utilization ratio was
0.22 (Table 1).
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table 2. Pathogens Recovered in Cases of Cathe-
ter-Associated Bloodstream Infection at a Teaching







Coagulase-negative staphylococci 10 (24)
Enterococcus species
Vancomycin susceptible 7 (17)
Vancomycin resistant 3 (7)
Staphylococcus aureus
Methicillin resistant 2 (5)




Pseudomonas aeruginosa 1 (2)
Escherichia coli 1 (2)
Klebsiella pneumoniae 1 (2)
Proteus mirabilis 1 (2)




C. albicans 5 (12)
Other 1 (2)
a Five infections (12%) had a polymicrobial etiology.
Catheter-Associated Bloodstream Infection Rates
A total of 42 episodes of CA-BSI were identified, correspond-
ing to an overall CA-BSI rate of 5.7 infections per 1,000
catheter-days (95% CI, 3.4-8.0). The mean CA-BSI rate in
the 4 units varied between 4.3 and 8.0 infections per 1,000
catheter-days (Table 1). There was no significant difference
in rates between the 4 wards (x2 for linear trend, 0.42;
).Pp .52
The rate of CA-BSI per 1,000 CVC-days steadily decreased
over the study period. The comparison of the first 6 months
(27 CA-BSIs during 3,481 catheter-days; 7.8 CA-BSIs per
1,000 catheter-days) with the following 7 months (15 CA-
BSIs per 3,856 catheter-days; 3.9 CA-BSIs per 1,000 catheter-
days) demonstrated a rate ratio of 0.50 (95% CI, 0.27-0.93).
Thirty-five patients (83%) with CA-BSI had nontunneled
catheters, 3 (7%) had totally implanted ports, and 2 (5%)
had tunneled catheters. Two patients had more than 1 type
of CVC. The types of catheters in patients who did not de-
velop a CA-BSI were not recorded.
Microbiological Characteristics
Twenty-four (57%) of the 42 cases of monomicrobial CA-
BSI were caused by gram-positive bacteria: 10 isolates (24%)
were coagulase-negative staphylococci, 10 (24%) were Entero-
coccus species, 3 (7%) were Staphylococcus aureus, and 1 (2%)
was another gram-positive organism. Gram-negative bacteria
caused 7 (17%) of the monomicrobial CA-BSIs: 1 isolate (2%)
was Pseudomonas aeruginosa, 1 (2%) was Escherichia coli, 1
(2%) was Proteus mirabilis, 1 (2%) was Enterobacter species,
1 (2%) was Klebsiella pneumoniae, and 2 (5%) were other
gram-negative organisms. Furthermore, 5 monomicrobial
CA-BSIs (12%) were caused by Candida albicans, and 1 (2%)
was caused by a Candida species other than C. albicans. Fi-
nally, 5 CA-BSIs (12%) were polymicrobial (Table 2). The
potential clonal relatedness of the microorganisms isolated
was not determined.
discussion
There is clearly a need for reference data for CA-BSIs and
other device-related infections in non-ICU patients. Although
multiple studies of the incidence of CA-BSIs in ICU patients
have been done,14-16 only a few investigators have examined
the incidence of these infections in non-ICU inpatient
wards.9,17-19 In our study, which, to our knowledge, is the
largest prospective cohort study performed in the United
States to date, we found the incidence of CA-BSIs in non-
ICU, general medical patients to be comparable to the rate
of CA-BSIs in ICU patients.
In this prospective study of CA-BSIs, we observed a total
of 7,337 catheter-days, which to our knowledge exceeds the
data reported elsewhere in the literature (4,949 catheter-
days).9 The device utilization ratio of central venous catheters
was 0.22, which is lower than the ratio reported in ICUs
(range, 0.51-0.69)7,9,20 but comparable to the 0.24 ratio for
non-ICU patients in a large survey of central venous access
devices in US teaching hospitals.7 However, given that the
majority of hospital beds are non-ICU beds, most patients
with an intravascular catheter will not be in ICUs.7
The device utilization ratio in our study was considerably
higher than that reported from the German national sur-
veillance system for general internal medicine wards (ratio,
0.051).9 Wischnewski et al.21 found a similarly low device
utilization ratio (0.061) among non-ICU patients in German
hospitals. The reasons for the difference in device utilization
in non-ICU wards between the United States and Europe are
not clear. This contrasts with the data for central venous
catheter use in ICUs, which is much more similar for US and
European ICUs.22
In the study by Vonberg et al.,9 the mean duration of hos-
pital stay was 8.2 days, which is longer than that in our
population (mean duration, 5.3 days). However, they in-
cluded community hospitals in their surveillance. Longer
length of stay and inclusion of primary and secondary care
institutions are both indicators for a lower general level of
acuity of illness in the study population, which may account
for lower rates of catheter utilization and risk of nosocomial
infection.
The overall rate of 5.7 CA-BSIs per 1,000 catheter-days we
found in our study is similar to the rate of 4.4 infections per
1,000 catheter-days that Vonberg and colleagues9 reported for
non-ICU medicine wards. The observed rate of CA-BSI in
our study is also very similar to the corresponding rate in
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our medical ICU (5.2 infections per 1,000 CVC-days) over
the same 13-month period and is comparable to the mean
rate of 5.7 infections per 1,000 CVC-days reported for medical
ICUs in the National Nosocomial Infection Surveillance Sys-
tem.20 The reason for this similarity with ICUs is unclear. In
a facility with a shortage of ICU beds, Mnatzaganian et al.19
examined ward patients who qualified as “critically ill,” on
the basis of criteria derived from the Society of Critical Care
Medicine, and reported lower rates of BSI among critically
ill patients housed in regular wards, compared with the rate
among ICU patients. Although other factors, such as anti-
biotic utilization and ward-specific processes, might influence
the incidence of CA-BSI, the findings of Mnatzaganian et al.19
argue against increased severity of illness as the primary risk
factor associated with high rates of CA-BSI.
Interestingly, there was a steady decrease in CA-BSI rates
during the study period. This trend may be associated with
increased staff awareness after receipt of feedback on CA-BSI
frequency, which has been shown to reduce infection rates.3
The educational module started on 2 of the wards in De-
cember of 2002 (ie, 9 months after the start of surveillance)
may have also contributed to the decreased rates, as found
in earlier studies involving educational approaches.23-25 The
association was not significant, possibly because the sample
size was small.
Finally, in our study units, 83% of CA-BSIs occurred in
patients with nontunneled central venous catheters. Only a
few patients (17%) had catheters meant for long-term use.
This reflects the current clinical use of intravascular catheters,
in that nontunneled catheters are the most frequently used
catheters in the ICU and on regular wards. Climo et al.7 found
46% of intravascular catheters to be nontunneled. Details of
catheter types were not reported from several other studies
of CA-BSIs, which prohibits a comparison of catheter-specific
infection rates.
This study has some limitations. We did not determine the
patients’ demographic characteristics, severity of illness, or
outcomes. Likewise, catheter insertion sites were not docu-
mented; therefore, infection rates attributable to a specific
insertion site were not computable. Communication of the
ongoing surveillance with unit managers and implementation
of the educational module may have increased staff adherence
to guidelines on proper infection control measures. This may
have caused differences between the CA-BSI rates observed
in the study wards and rates in non-ICU units without on-
going surveillance and feedback of rates to staff. Finally, this
study was performed in a large, academic, tertiary care hos-
pital, and our results may not be generalizable to nonaca-
demic medical centers.
To our knowledge, this is the first study to systematically
and prospectively determine the incidence of CA-BSIs among
non-ICU patients in the United States. We observed infection
rates comparable to those in medical ICUs. Given the dif-
ferences between service delivery in ICUs and non-ICU wards
(which are organizationally more diverse than ICUs), pre-
vention and control of CA-BSIs outside the ICU may require
different strategies. Studies of clinicians’ knowledge of and
attitude toward central venous catheter insertion and care on
regular wards could help establish such strategies. More data
to serve as a valid reference for nosocomial infections and
their predisposing factors on non-ICU medical wards is war-
ranted. The relatively high incidence of CA-BSI found in this
study supports the need for expanding routine CA-BSI sur-
veillance beyond the ICU. However, such surveillance may
be limited by infection control resources in most hospitals.
Computer-assisted surveillance methods may allow this to
occur in the near future.26
The prevention of healthcare-associated infections is an
important goal to improve overall quality of care. Recently,
the Institute for Healthcare Improvement, for instance, started
a major campaign (known as the “5 Million Lives Campaign”)
to save lives lost due to healthcare-associated infections and
other adverse events in hospitals. The campaign cites the
prevention of catheter-related infections as one of its goals
but focuses only on ICU patients.27 The results of this study
highlight the need for improved surveillance for these infec-
tions outside the ICU and for identification or development
of prevention measures that can be applied in non-ICU
settings.
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